Far Westerns with digoxigenin-conjugated protein phosphatase-1 (PP1) catalytic subunit identified PP1-binding proteins in extracts from bovine, rat, and human brain. A major 70-kDa PP1-binding protein was purified from bovine brain cortex plasma membranes, using affinity chromatography on the immobilized phosphatase inhibitor, microcystin-LR. Mixed peptide sequencing following cyanogen bromide digestion identified the 70-kDa membrane-bound PP1-binding protein as bovine neurofilament-L (NF-L). NF-L was the major PP1-binding protein in purified preparations of bovine spinal cord neurofilaments and the cytoskeletal compartment known as post-synaptic density, purified from rat brain cortex. Bovine neurofilaments, at nanomolar concentrations, inhibited the phosphorylase phosphatase activity of rabbit skeletal muscle PP1 catalytic subunit but not the activity of PP2A, another major serine/ threonine phosphatase. PP1 binding to bovine NF-L was mapped to the head region. This was confirmed by both binding and inhibition of PP1 by recombinant human NF-L fragments. Together, these studies indicate that NF-L fulfills many of the biochemical criteria established for a PP1-targeting subunit and suggest that NF-L may target the functions of PP1 in membranes and cytoskeleton of mammalian neurons.
Modification of signal transduction pathways within the synapse following neuronal activity is thought to be a mechanism underlying learning and memory in higher organisms. Protein phosphatase-1 (PP1), 1 a major protein serine/threonine phosphatase, controls numerous physiological processes in neuronal and non-neuronal tissues (1) (2) (3) . Regulation of specific PP1 pools has been implicated in neuronal plasticity changes linked to simple forms of learning and memory. For example, PP1 bound to plasma membranes controls the serotonin-sensitive K ϩ channel that regulates neurotransmitter release from sensory neurons and short term sensitization of tail and siphon withdrawal reflexes in Aplysia californica (4) . In the mammalian brain, PP1 is concentrated in dendritic spines where it dephosphorylates phosphoproteins like CaMKII (5-7) calcium channels (8) , and NMDA (9 -11) , and AMPA receptor channels (12) (13) to modulate synaptic plasticity, characterized as long term potentiation (14) and long term depression (15) . However, the mechanism by which PP1 is localized to specific neuronal compartments and the significance of PP1 localization for neuronal signaling remains largely unknown.
Studies of cellular and molecular mechanisms that control PP1 activity in all eukaryotic cells have emphasized a recurrent regulatory paradigm, whereby the PP1 catalytic subunit is associated with distinct regulatory subunits that define its subcellular distribution and modify its biochemical properties. In this manner, the regulatory subunits dictate the diverse functions of PP1 in the eukaryotic cell (16) . Biochemical isolation of PP1 complexes (17) , use of yeast two-hybrid protein interaction screens (18) , and genetic manipulations of the PP1 catalytic subunit in yeast (19 -20) and fruit flies (21) have identified more than 40 putative PP1-targeting subunits.
Although the precise mechanisms regulating PP1 activity in the mammalian nervous system have not been fully investigated, a number of candidate PP1 regulators have been identified. Efforts to identify PP1 regulators using a yeast twohybrid screen of a rat brain cDNA library yielded spinophilin, a protein that is localized to dendritic spines (22) . Physiological studies indicate that disrupting the PP1⅐spinophilin complex modifies ion gating by the AMPA receptor (12) , a known PP1 substrate (13) . PP1 was also immunoprecipitated from rat brain extracts with yotiao, a PKA-anchoring protein (11) . These studies suggest that yotiao, which also associates with the NR1A subunit of the NMDA receptor (11) , assembles a PKA-PP1 signaling module that regulates synaptic transmission mediated by the NMDA receptor. These two examples emphasized the importance of PP1 targeting for neuronal signaling.
In this study, we utilized affinity chromatography combined with a far Western assay to identify and isolate PP1-binding proteins in different subcellular compartments in the mammalian brain. A major 70-kDa PP1-binding protein seen in particulate fractions from cortex and hippocampus in rat, bovine, and human brain was extensively purified and identified by peptide sequencing as neurofilament light chain (NF-L), a component of the intermediate filament network that defines axonal caliber (23) . Biochemical studies of purified bovine neurofilaments and recombinant human NF-L established that NF-L possessed many, if not all, of the properties of a bona fide PP1-targeting subunit. The role of NF-L in PP1 targeting to neuronal membranes and cytoskeleton and its potential for regulating the dephosphorylation of phosphoproteins implicated in synaptic plasticity are discussed.
EXPERIMENTAL PROCEDURES
Materials-Thrombin and Staphyloccocus V8 protease were purchased from Sigma. Microcystin LR was purchased from Calbiochem. Phosphorylase kinase and phosphorylase b were from Life Technologies, Inc. [␥-32 P]ATP (3000 Ci/mmol) was purchased from NEN Life Science Products. GST fusion constructs (pGEX4T vector) for expressing recombinant human NF-L were provided by Dr. Hideyuki Mukai, Kobe University, Japan (24) . After isopropyl-1-thio-␤-D-galactopyranoside-induced expression in Escherichia coli BL21 as described by Mukai et al. (24) , the GST fusion proteins were purified on glutathione-Sepharose according to manufacturer's instructions (Amersham Pharmacia Biotech). The yeast two-hybrid vector pPC86, containing human NF-L rod and full-length NF-L, was kindly provided by Dr. Wally Ip, University of Cincinnati (25) . Human PP1␣ in the pPC62 two-hybrid vector was provided by Dr. Patrick Allen of Rockefeller University (22) . Cortex and hippocampus dissected from rat brain were provided by Dr. Wilkie Wilson, Duke University. Rat brain post-synaptic density fractions were provided by Dr. Roger Colbran of Vanderbilt University (5). Dr. Roger Colbran also provided us with purified rat brain CaMKII. PP1 and PP2A catalytic subunits were purified from rabbit skeletal muscle according to DeGuzman and Lee (26) .
Antibodies-Monoclonal antibodies (dilutions used for Western immunoblotting are in parentheses) against NF-L (1:1000), NF-M (1: 1000), NF-H (1:500), and synaptophysin (1:500) were purchased from Sigma. A monoclonal antibody against neurabin I (1:250) was obtained from Signal Transduction Laboratories. Anti-PSD-95 (1:1000) monoclonal antibody was kindly provided by Dr. Morgan Sheng of Harvard University. Isoform-specific anti-PP1 polyclonal antibodies (all 1:1000) were gifts from Dr. Emma Villa-Moruzzi, University of Pisa, Italy (27) and Dr. Brian Wadzinski, Vanderbilt University (5). The anti-spinophilin (1:2000) polyclonal antibody was provided by Dr. Patrick Allen, Rockefeller University (22) .
Preparation of Bovine Brain Plasma Membranes-Bovine brain cortex was homogenized in 2 volumes of 50 mM Tris-HCl, pH 7.5, 1 mM EDTA, 1 mM EGTA, 10 mM NaCl, 1 mM benzamidine, 1 mM PMSF, 10 g/ml pepstatin, and 10 g/ml aprotinin. Crude particulate and soluble fractions were separated by centrifugation at 100,000 ϫ g for 90 min.
Plasma membranes were prepared essentially as described by Ozols (28) . Briefly, bovine brain was homogenized in 5 volumes of 0.25 M STM buffer (0.25 M sucrose, 5 mM Tris-HCl, pH 7.2, 1 mM MgCl 2 , 0.1% (v/v) ␤-mercaptoethanol, 0.1 mM EDTA, 1 mM benzamidine, and 1 mM PMSF). After filtration through moistened gauze, homogenate was centrifuged at 280 ϫ g for 5 min. A second homogenization of the pellet was followed by centrifugation at 280 ϫ g for 5 min. The two supernatants were combined and centrifuged at 1,500 ϫ g for 10 min. The pellet was resuspended in STM buffer, and sucrose concentration was raised to 1.42 M. The sample was overlaid with a small volume of 0.25 M STM and centrifuged at 82,000 ϫ g for 1 h. The interface was resuspended in 0.25 M STM and centrifuged at 1,500 ϫ g for 10 min. The final pellet (representing purified plasma membranes) was resuspended in 0.25 M STM and stored at Ϫ80°C.
Analysis of PP1-binding Proteins-PP1-binding proteins were identified by a far Western procedure (29) . Briefly, recombinant rabbit PP1␣ was covalently coupled to digoxigenin using the digoxigenin labeling kit (Roche Molecular Biochemicals). Protein samples, containing PP1 binding proteins, were separated by 10% (w/v) SDS-PAGE and electrophoretically transferred to a PVDF membrane. The membrane was blocked with 4% (w/v) skim milk dissolved in 10 mM Tris-HCl, pH 7.5, and 150 mM NaCl, and PP1-binding proteins were detected by incubating the membrane with digoxigenin-conjugated PP1␣ followed by an anti-digoxigenin antibody (Roche Molecular Biochemicals). Antibody binding was visualized by the alkaline phosphatase reaction.
Microcystin LR-coupled Sepharose was prepared as described by Campos et al. (17) . Brain extracts were incubated with microcystin LR-Sepharose for 30 min at 4°C to allow the binding of PP1 and any associated proteins. The column was washed extensively with buffer A (50 mM triethanolamine HCl, pH 7.5, 0.1 mM EGTA, 5% (v/v) glycerol, 0.1% (v/v) ␤-mercaptoethanol, 1 mM benzamidine, and 1 mM PMSF), followed by buffer A containing NaCl concentrations up to 0.5 M. PP1 and PP1-binding proteins were eluted using buffer A containing 3 M sodium thiocyanate.
Mixed Peptide Sequencing-PP1-binding proteins were sequenced according to Damer et al. (30) . Protein samples were separated by SDS-PAGE and transferred electrophoretically to PVDF membranes. The transferred proteins were visualized with Amido Black (1 mg/ml in 5% acetic acid and 10% methanol) for approximately 1 min, washed with 5% acetic acid and 10% methanol, and then with several changes of water. The membrane was air-dried, and individual stained bands were excised and placed into microcentrifuge tubes. The membrane slice was washed 3 times with water and then methanol. CNBr (100 l, 500 mg/ml in 70% formic acid) was added, and partial peptide digestion was performed for 90 min at room temperature. The reaction was stopped by removing the membrane and washing 3 times with water and once with methanol. The pieces were placed into an Applied Biosystems 494 automated sequenator. A single run of Edman sequencing (8 -18 cycles of pulsed liquid chemistry) was carried out, and the mixed peptide sequences were sorted and matched to the available data bases with the FASTF or TFASTF algorithms.
Preparation of Bovine Spinal Cord Neurofilaments-Native neurofilaments were prepared by combining two existing protocols (31, 32) . Bovine spinal cord was homogenized in 2 volumes of 1 mM sodium phosphate, pH 8.0, 5 mM EDTA, and 1 mM ␤-mercaptoethanol and centrifuged at 100,000 ϫ g for 30 min. The pellet was treated in 2 M urea at 4°C for 1 h and recentrifuged at 100,000 ϫ g. The supernatant was adjusted to a final concentration of 6 M urea in 10 mM sodium phosphate, pH 7.5, containing 5 mM EDTA, and 0.1% (v/v) ␤-mercaptoethanol. The sample was then applied to a DEAE-cellulose column and the neurofilaments eluted with a gradient of 25-200 mM NaCl. Fractions containing neurofilaments, determined by their electrophoretic migration and immunoreactivity with anti-NF-L, NF-M, and NF-H antibodies, were pooled and dialyzed into 10 mM PIPES, pH 6.8, 150 mM NaCl, 1 mM MgCl 2 , 0.1 mM EGTA, 0.1 mM EDTA, 0.1 mM dithiothreitol, 0.1 mM PMSF, and 1 g/ml leupeptin. The neurofilament preparation was heated in a boiling water bath for 5 min to destroy endogenous kinase and phosphatase activity (32) and stored at Ϫ80°C.
Phosphorylase Phosphatase Assays-Protein phosphatase activity was assayed as described by Shenolikar and Ingebritsen (33) . Assays were performed in 50 mM Tris-HCl, pH 7.0, 1 mg/ml BSA, 1 mM EDTA, 0.1% (v/v) ␤-mercaptoethanol, using 20 M 32 P-labeled phosphorylase a as substrate. The phosphatase was preincubated with potential regulators at 37°C for 10 min prior to the addition of substrate. The assay was performed for 10 min at 37°C. Reaction was stopped by addition of 200 l of 20% (w/v) trichloroacetic acid and 50 l of BSA (10 mg/ml). 32 P released into the supernatant (200 l) was monitored by liquid scintillation counting. The assay was restricted to a maximum of 20% release of total phosphate to ensure linearity.
RESULTS

Analysis of PP1-binding Proteins in Mammalian Brain-
Analysis of the 100,000 ϫ g pellet and supernatant from rat hippocampus and cortex was undertaken using far Westerns (overlays) with digoxigenin-coupled human PP1␣ as ligand detected 10 -12 polypeptides in both fractions. Essentially similar results were obtained by Strack and co-workers (34) using PP1␥1 as the ligand. Two polypeptides of apparent molecular mass of 70 and 140 kDa represented the major PP1-binding proteins in the particulate fraction from both hippocampus and cortex (Fig. 1A) . By comparison, two closely migrating PP1-binding proteins of approximately 35 and 40 kDa represented the major polypeptides overlaid with the digoxigenin-conjugated PP1 in the soluble fraction or supernatants from both rat brain regions. Analysis of freshly isolated bovine and human brain hippocampus and cortex yielded essentially similar results (data not shown). However, in bovine brain cortex, the 70-kDa polypeptide was the most predominant PP1-binding protein in overlays of particulate and soluble fractions (Fig.  1B) .
Isolation of the 70-kDa PP1-binding Protein from Bovine Brain-Plasma membranes represented a major subcellular component in the 100,000 ϫ g pellet from bovine brain cortex. The particulate fraction from bovine cortex was extensively purified using a sucrose density gradient. The interface between 0.25 and 1.42 M sucrose represented highly purified plasma membranes. PP1 overlay of plasma membranes indicated that the 70-kDa polypeptide was the major PP1-binding protein in this subcellular compartment (Fig. 2) . A significant portion (approximately 20%) of 70-kDa PP1-binding protein was extracted from membranes by buffers containing 0.5 M NaCl, often used to extract PP1 from particulate fractions (35) . The remainder of the 70-kDa protein resisted extraction in buffers containing the non-ionic detergent, Triton X-100. Homogenization of this fraction in buffers containing 1% SDS solubilized the remaining 70-kDa PP1-binding protein.
Affinity chromatography on the immobilized phosphatase inhibitor, microcystin-LR, has been used to isolate PP1 complexes from many different tissue extracts (17) . Thus, the 0.5 M NaCl extract of the neuronal plasma membranes was dialyzed and subjected to chromatography on microcystin-LR-Sepharose (Fig. 3 ). All PP1-binding proteins present in the salt extract bound tightly to microcystin-LR-Sepharose and were not eluted by buffers containing either 0.1 or 0.5 M NaCl. However, all the PP1-binding proteins were quantitatively released in buffer containing 3 M sodium thiocyanate, which elutes all microcystin-LR-bound phosphatases (17) . The eluted proteins were dialyzed against 10 mM Tris-HCl, pH 7.5, freeze-dried, and subjected to SDS-PAGE. Following electrophoretic transfer to PVDF, the region of the membrane containing the 70-kDa PP1-binding peptide was excised and sequenced. Repeated failure to obtain an amino acid sequence indicated that the 70-kDa protein was blocked at its N terminus (30) . Thus, the peptide was partially digested with CNBr and subjected to mixed peptide sequencing (30) . The three sequences identified the 70-kDa PP1-binding protein as bovine neurofilament-L (Table I ). The 70-kDa PP1-binding protein in the 1% SDS extract was also sequenced following CNBr digestion on PVDF membrane. We obtained four peptide sequences that also identified this protein as bovine neurofilament-L (data not shown). The less abundant 140-and 190-kDa PP1-binding proteins that coeluted with NF-L from microcystin-Sepharose were identified by microsequencing as the recently identified PP1-binding proteins, neurabin I (36) and neurabin II/spinophilin (22, 37) . Efforts to obtain primary sequence from the 230-kDa PP1-binding polypeptide were unsuccessful, due to its low concentration in the 3 M sodium thiocyanate eluate.
Immunoblotting the microcystin-LR-Sepharose eluate with anti-PP1c and anti-NF-L monoclonal antibodies established the presence of both PP1 catalytic subunit and NF-L (Fig. 3) . NF-L exists in neurons as a triplet complex with NF-M and NF-H (38). These two proteins were also present in the eluate from microcystin-Sepharose as determined by immunoblotting with anti-NF-M and anti-NF-H antibodies (data not shown). This suggested that PP1 existed as a complex containing all three triplet proteins.
The 100,000 ϫ g supernatant also contained a major 70-kDa PP1-binding protein. To investigate whether this also represented NF-L, we purified this protein by fractionating the 100,000 ϫ g supernatant with 50% saturated ammonium sulfate, followed by two sequential ion exchange chromatography steps on DEAE-cellulose (data not shown). The soluble 70-kDa PP1-binding protein was eluted from the final DEAE-cellulose column with a gradient of 0 to 1.0 M NaCl, and its elution was monitored using the PP1 far Western assay. The protein was then dialyzed against 10 mM Tris-HCl, pH 7.5, freeze-dried, and subjected to SDS-PAGE. Following its transfer to PVDF membrane, the 70-kDa polypeptide was excised, digested with CNBr, and subjected to mixed peptide sequencing as described above. All four peptides were present in a single target protein in the data base that was not neurofilament-L. The four sequences totaled 44 amino acids that showed 86% sequence identity with the bovine heat-shock related protein, hsc70 (Table I) .
Association of PP1 with Purified Neurofilaments-Earlier studies had shown that PP1 and PP2A were both associated with purified neurofilaments. However, the molecular basis for the association of these enzymes with the neuronal intermediate filament proteins was not determined (39 -40) . To establish PP1 binding to neurofilaments, we isolated bovine spinal cord Rat hippocampus and cortex were dissected, homogenized, and fractionated into the 100,000 ϫ g particulate fraction and supernatant as described under "Experimental Procedures." The fractions (50 g of total protein) were subjected to 10% (w/v) SDS-PAGE and analyzed for PP1 binding using the far Western assay (A). Fractions from bovine brain cortex were analyzed in a similar manner (B). Recombinant GST-G M (residues 1-240), representing the PP1-binding domain from human skeletal muscle glycogen targeting subunit, was used as positive control.
FIG. 2.
Extraction of PP1-binding proteins from purified bovine brain plasma membranes. Plasma membranes were purified from bovine brain cortex as described under "Experimental Procedures." The membranes (50 g of total protein) were successively extracted with Tris-HCl, pH 7.5, containing 0.5 M NaCl, 0.1% Triton X-100, and 1.0% SDS. These fractions were subjected to SDS-PAGE and far Western analyses as described in Fig. 1 . Binding of proteins in each fraction to digoxigenin-conjugated PP1c is shown. Protein loading was adjusted to account for the total protein in the starting material.
neurofilaments and analyzed their binding to the PP1 catalytic subunit in the far Western assay. Purified neurofilaments contained the neurofilament triplet proteins, NF-L, NF-M, and NF-H, and GFAP, the glial fibrillary acidic protein (Fig. 4A) . By using a range of protein concentrations, PP1 binding was demonstrated with NF-L (Fig. 4B) . At the highest concentrations of neurofilaments analyzed, PP1 binding was also seen with GFAP. However, NF-L showed approximately 50 -100-fold higher PP1 binding than GFAP, and no PP1 was bound to NF-M or NF-H.
Immunoblotting with anti-PP1c antibodies showed that as purified, the bovine neurofilaments contained no PP1 catalytic subunit (Fig. 3) and failed to bind microcystin-LR-Sepharose (data not shown). This lent support to the idea that association of the triplet proteins with this affinity matrix (described above) required their interaction with PP1 and/or another microcystin-sensitive phosphatase. Thus, co-purification of PP1 and NF-L (as well as NF-H and NF-M) on microcystin-LRSepharose may indicate a preformed complex of these proteins in brain extracts. (41) and regulates postsynaptic events known as LTP (14) and LTD (15) in rat hippocampal neurons. To examine the distribution of the neurofilament triplet proteins and other PP1 regulators in the synapse, we analyzed the post-nuclear supernatant (PNS), synaptosomes (SYN), and post-synaptic density (PSD), isolated by the sequential fractionation of rat brain cortex (5). Immunoblotting established the presence of the post-synaptic protein, PSD-95, and the absence of synaptophysin, a presynaptic protein, thus confirming the purity of the PSD preparation (Fig. 5) . Earlier work (41) had shown that two PP1 isoforms, PP1␣ and PP1␥1, were enriched in dendritic spines. Consistent with this, we found that of the three PP1 gene products expressed in the mammalian brain, only PP1␣ and PP1␥1 were concentrated in PSD. By comparison, PP1␤ was distributed evenly throughout the PNS, SYN, and PSD. Interestingly, the myosin-binding subunit, M 110 , was also present in the PSD (data not shown), and two other recently identified PP1-binding proteins, neurabin I and neurabin II/spinophilin, were concentrated in PSD fraction. Despite some controversy about the presence of neurofilaments in spines (41), like others (42), we found that the three triplet proteins, NF-L, NF-M, and NF-H, were greatly enriched in purified PSD preparations. FIG. 3 . Affinity isolation of PP1 complexes from bovine brain membranes. Bovine brain plasma membranes were extracted with buffer containing 0.5 M NaCl as described in Fig. 2 . The extract was dialyzed extensively against 10 mM Tris-HCl, pH 7.5, containing 0.1 mM EDTA and 15 mM ␤-mercaptoethanol before applying to microcystin-LR-Sepharose. The column was washed with 20 volumes each of buffers containing 0.1 M NaCl and 0.5 M NaCl before eluting with 3 M NaSCN. The membrane extract (30 g of protein) and equivalent amounts of each column fraction were subjected to SDS-PAGE and far Western analysis with digoxigenin-coupled PP1 catalytic subunit. Purified bovine spinal cord neurofilaments were used as control. The fractions were also analyzed for immunoreactivity with anti-PP1c and anti-NF-L antibodies by immunoblotting. b Target protein was identified as bovine dnaX-type molecular chaperone Hsc70.
Distribution of PP1 Catalytic Subunits and PP1-binding Proteins in the Synapse-PP1 is concentrated in dendrites
FIG. 4. PP1 binding to purified bovine spinal cord neurofilaments. Varying concentrations of purified bovine neurofilaments were subjected to 10% (w/v) SDS-PAGE (A). Following electrophoretic transfer to PVDF membrane, PP1 binding was analyzed by far Westerns (B). GST-G M (residues 1-240) was used as control (not shown).
Mapping the PP1-binding Domain in Bovine Neurofilament-L-To define PP1-binding to bovine NF-L, purified spinal cord neurofilaments were subjected to SDS-PAGE. The polypeptide representing NF-L was excised, digested with Staphylococcus aureus V8 protease for 30 min and the resulting peptides separated on SDS-PAGE (Fig. 6 ). In addition to undigested NF-L, six peptides were obtained. When subjected to far Western analysis with digoxigenin-conjugated PP1 catalytic subunit, the full-length NF-L and two fragments of apparent molecular mass 45 and 38 kDa bound PP1. In contrast, four peptides of apparent molecular mass 52, 31, 24, and 16 kDa failed to bind PP1c. The two PP1-binding peptides were transferred to PDVF membrane and subjected to repeated microsequencing. No peptide sequence was obtained from either peptide, suggesting that they represented the blocked N terminus of bovine NF-L. To confirm this, we undertook a second round of sequencing following CNBr digestion of the 45-and 38-kDa peptides. The sequences obtained clearly defined the PP1-binding peptides as derived from the N terminus of NF-L encompassing the head region and small portion of the rod region (Fig. 6) . We also obtained N-terminal sequences for the 52-and 31-kDa peptides that failed to bind PP1c in the far Western assay. Their Nterminal sequences established that both peptides were generated by V8 cleavage within the rod region of NF-L and based upon their size, they most likely extended to the extreme C terminus of NF-L. This provided evidence that PP1 binding occurred with the head region of bovine NF-L although a contribution for part of the rod region in PP1 binding could not be excluded.
Analysis of PP1-binding to Recombinant Human NF-L-To
analyze further PP1 binding to the head region of NF-L, we expressed human NF-L and selected fragments in bacteria as fusion proteins with GST (Fig. 7A) . PP1c bound weakly to GST-NF-L in the far Western assay (Fig. 7B) . Digestion of GST-NFL with thrombin yielded free NF-L and significantly enhanced its binding to PP1c. At equivalent protein concentrations, GST-NFL showed approximately 50 -100-fold lower binding to PP1 than free NF-L. GST fusion proteins containing either the head and rod region or the tail region of human NF-L were also expressed. Far Westerns with PP1 catalytic subunit confirmed that the head-rod region but not the tail region of human NF-L bound PP1c (Fig. 7C) . Thrombin cleavage of the GST-NF-L-head/rod yielded a 37-kDa polypeptide, which like NF-L, showed greatly enhanced binding to digoxigenin-coupled PP1c (data not shown). These data indicated that GST fusion to the N terminus of NF-L protein and the head/rod peptide impaired PP1c binding and hinted at the head region as the site for PP1 binding.
We also analyzed the binding of human PP1␣ to human NF-L in the yeast two-hybrid assay. However, no interaction was seen between NF-L fused to the GAL4 DNA-binding domain and PP1␣ fused to the GAL4 activation domain. The latter had been used in earlier studies to clone spinophilin from a yeast two-hybrid library (22) . Insertions of NF-L and PP1␣ cDNAs in the opposing two-hybrid vectors also failed to show any association. This may be because the fusion of either the GAL4 DNA binding or transactivation domains, to the N terminus of NF-L, impaired PP1c binding, consistent with PP1 binding near the N terminus of NF-L.
Regulation of PP1 Activity by Neurofilaments-Many targeting subunits that bind the PP1 catalytic subunit also modify its substrate specificity (16) . This is most often seen as inhibition of phosphorylase phosphatase activity when the putative targeting subunits are added to the PP1 assay. To establish the role of neurofilaments as PP1 targeting subunits, we analyzed their effect on phosphorylase a dephosphorylation by purified rabbit skeletal muscle PP1c. Bovine neurofilaments inhibited the enzyme in a dose-dependent manner with half-maximal inhibition seen with approximately 1 g of total protein (Fig.  8A) . Based on the relative content of NF-H, NF-M, NF-L, and GFAP in the neurofilament preparation, an IC 50 for PP1 inhibition was estimated at approximately 40 nM NF-L. In contrast, bovine neurofilaments at much higher concentrations had no effect on PP2A activity using the same substrate. Interestingly, bovine neurofilaments had little or no effect on the dephosphorylation of autophosphorylated rat brain CaMKII ␣-subunit by PP1c (data not shown).
Neurofilaments are highly phosphorylated proteins and could function as competitive inhibitors of protein serine/threonine phosphatases, although earlier studies showed that purified PP1c did not dephosphorylate neurofilaments (44) , and it seemed unlikely that neurofilaments, with IC 50 near 40 nM, could effectively compete with 20 M phosphorylase a as substrate in the PP1 assay. Morever, neurofilaments specifically inhibited PP1c and had no effect on another phosphorylase phosphatase, PP2A, which is also a significantly better NF-L phosphatase (44) . To exclude this possibility, neurofilaments were dephosphorylated by prolonged incubation (37°C for 10 h) with near equimolar concentration of calf intestinal alkaline phosphatase, previously shown to dephosphorylate neurofilaments (45) . The in vitro dephosphorylated neurofilaments bound equally well to PP1c in the far Western assay and also inhibited PP1c activity in essentially identical manner (data not shown).
Recombinant human NF-L expressed as a GST fusion also inhibited PP1 activity albeit at much higher concentrations FIG. 5 . Analysis of PP1 and PP1-binding proteins in fractions from rat brain cortex. Successive fractionation of rat brain cortex yielded the PNS, SYN, and PSD. 10 g of total protein were loaded in each lane. Immunoblotting for PSD-95 monitored the purification of the PSD. The absence of synaptophysin, a presynaptic protein, demonstrated the purity of the PSD preparation. The three PP1 isoforms expressed in rat brain were analyzed using anti-peptide antibodies specific for the C termini of PP1␣, PP1␤, and PP1␥1. Known PP1-binding proteins, neurabin I and spinophilin/neurabin II, were analyzed along with the neurofilament triplet proteins, NF-L, NF-M, and NF-H. than isolated neurofilaments. The IC 50 for PP1 inhibition by GST fusion containing full-length NF-L was slightly above 1 M (Fig. 8B) , perhaps reflecting the greatly reduced binding affinity of this fusion protein for PP1c as seen in the far Western assay (Fig. 7B ) . The GST-NF-L head-rod region also inhibited PP1 activity with IC 50 between 8 and 10 M, which may correspond to its reduced binding to PP1c compared with GST-NF-L in the far Western assay (Fig. 7C ) . No inhibition of PP1 activity was seen with GST alone. Addition of GST-NF-L tail resulted in less than 10% reduction in PP1c activity over the concentration range of 0.2 to 20 M, consistent with its failure to bind PP1c in the far Western assay. These data suggested that PP1 binding and inhibition was largely mediated through the head region of NF-L.
DISCUSSION
Protein phosphatase-1 dephosphorylates receptors, ion channels, and other signaling molecules to regulate neuronal plasticity (46 -47) . To identify potential PP1 regulators, we analyzed PP1 binding to proteins in different subcellular fractions from bovine brain, focusing on neuronal plasma membranes. Combining affinity chromatography on microcystin-LR-Sepharose, widely used to isolate pre-existing phosphatase complexes in cell extracts (17) , with a far Western assay, we identified four PP1-binding proteins in extracts of bovine brain plasma membranes. Microsequencing identified three proteins of apparent mass of 70, 140, and 190 kDa as neurofilament-L (NF-L), spinophilin/neurabin II, and neurabin I, respectively. The 230-kDa protein was not successfully sequenced but, based on its size, could represent the recently identified PP1-binding protein, yotiao (11) . Like many known PP1-targeting subunits, NF-L and the two neurabins (22, 48) 2 potently inhibited PP1c activity against phosphorylase a. Yotiao, on the other hand, enhanced phosphorylase a dephosphorylation (11) . Neurabin I and spinophilin/neurabin II contained the highly conserved KIXF motif that mediates PP1 association with many regulators (49) . In contrast, NF-L and yotiao (11) bind PP1 by novel structural determinants and may utilize different mechanisms to modulate PP1 activity. Nevertheless, our biochemical studies established that NF-L possessed the properties, namely 2 R. T. Terry-Lorenzo and S. Shenolikar, unpublished data. stable association with PP1c and its altered activity, reported for other targeting subunits. This qualifies NF-L as a candidate regulator that may dictate functions of PP1 in neuronal membranes and cytoskeleton.
By using immunocytochemistry, we observed extensive colocalization of PP1␣ and PP1␥1 with NF-L in axons and dendrites of cultured dorsal root ganglion and hippocampal neurons. 3 However, because of the abundance of these proteins, particularly NF-L, these data are difficult to interpret. Similar difficulties are experienced with myosin (50) and tau, a microtubule-binding protein, that also bind PP1 (51) . Thus, the present studies focused on defining the molecular basis for PP1 association with neurofilament proteins and their effects on phosphatase activity. In this regard, our experiments were modeled on the myosin-bound PP1 that associates with myosin through an intermediate protein, the M 110 or myosin-targeting subunit (52) . Peptides representing the PP1-binding site in the M 110 subunit disrupted the myosin phosphatase and established the role of PP1 in smooth muscle relaxation (53) . By comparison, PP1 binds directly to bovine and human NF-L most likely within the head region. The assembly of NF-L, NF-M, and NF-H into neurofilaments that occurs through their rod regions did not exclude PP1 binding. Indeed, the three triplet proteins co-purified with PP1 on microcystin-LR-Sepharose and neurofilaments containing stoichiometric amounts of the triplet proteins potently inhibited the phosphorylase phosphatase activity of PP1c. Thus, by analyzing PP1 binding to NF-L, we have come closer to providing the tools necessary to establish the physiological role of the neurofilament-bound phosphatase.
Like the myosin-bound PP1 and perhaps the tau-bound phosphatase, which regulate the phosphorylation state of myosin and tau, respectively, the NF-L-bound PP1 may also control the phosphorylation of NF-L and other neurofilament proteins. In this regard, PKA phosphorylates NF-L at serine 55 and also perhaps serine 2 (54) in the head region of NF-L and regulates neurofilament assembly in vitro (55) (56) and in vivo (57) (58) . The fatty acid-and Rho-activated protein kinase, PKN, also phosphorylates NFL in the head region at different sites, serine 26 and serine 57, to inhibit polymerization (24) . Thus, PP1 association with the NF-L head region may position the enzyme to dephosphorylate one or more of these phosphorylated serines and promote neurofilament assembly. On the other hand, PP2A, which also associates with neurofilaments, may regulate their extensive phosphorylations that occur on the tail regions of NF-L, NF-M, and NF-H (39 -40) . In this regard, the cell-permeable phosphatase inhibitor, calyculin A, shows a greater preference for PP1 than PP2A and was much more effective than okadaic acid, a better PP2A inhibitor, in dissociating neurofilament network in cultured neurons (44) . The high concentration of okadaic acid needed to promote NF-L phosphorylation and disrupt neurofilaments (44) also argued for a role for PP1 in neurofilament assembly. On the other hand, in vitro studies showed that purified rabbit skeletal muscle PP1 catalytic subunit was a poor NF-L phosphatase (44) , and PP2A accounted for greater than 75% of the NF-L phosphatase activity in brain extracts (40) .
Another scenario may be that the NF-L-bound phosphatase regulates other phosphoproteins localized close to the NF-L head region. For example, the myosin-bound phosphatase dephosphorylates adducin, a membrane-cytoskeletal protein that is highly phosphorylated in mammalian synapse (59) , and moesin, a member of the ERM family of actin-binding proteins expressed in many polarized cells (60) . In this regard, it should be noted that along with NF-L, NF-M, and NF-H, M 110 , neurabin I, and spinophilin/neurabin II were also present in the post-synaptic density from rat brain cortex. The cytoskeletal specialization known as the PSD harbors signaling molecules that either respond to or control the function of postsynaptic neurotransmitter receptors and ion channels and thus regulate neuronal excitability. In this regard, NF-L associates with NR1A subunits of the NMDA receptor (61), a known substrate of PP1 in the post-synaptic membrane (9 -11 ). Another PP1 substrate, CaMKII (5-7), associates with the NR1 (62) and NR2A/B (63-64) subunits of the NMDA-R. Whereas this may position CaMKII near the NMDA receptor channel to respond quickly to calcium entry, it also places the NF-L-bound PP1 in close proximity to two substrates, CaMKII and NMDA-R, which is also a substrate for CaMKII (65) , to downregulate the calcium signal. An analogous mechanism has been proposed for PKA regulation of NMDA-R whereby the NR2B-binding protein, yotiao, binds both PKA and PP1 and regulates the NMDA receptor function in response to cAMP (11) . Thus, two distinct PP1 complexes may be formed to transduce signals from the second messengers, calcium and cAMP, and control NMDA receptor function.
Interestingly, we found that the major 70-kDa PP1-binding 3 K. Whitney and S. Shenolikar, unpublished data.
FIG. 8. Inhibition of phosphorylase phosphatase of PP1 by neurofilaments.
A, the phosphorylase a phosphatase activity of purified rabbit skeletal muscle PP1 (circles) and PP2A (squares) was analyzed as described under "Experimental Procedures" in the presence of increasing amounts of bovine spinal cord neurofilaments. B shows the inhibition of phosphorylase phosphatase activity of PP1c by GST-NF-L (circles), GST-NF-L head-rod region (triangles), and GST alone (squares). Each panel shows a representative figure from three separate experiments each carried out in duplicate. The standard error for each assay condition was less than 5%.
protein in bovine brain cytosol was Hsc70, a protein related to Hsp70 and Hsp90, which were isolated by microcystin-LR affinity chromatography of skeletal muscle extracts (30) . This may indicate that multiple members of the heat-shock protein family bind PP1 and/or other microcystin-sensitive phosphatases. More relevant to these studies, a sequence in Hsc70 (GER-AMTKDNNLLGKF) was found in its entirety in a PSD-associated protein (43) suggesting that this apparently soluble protein may also regulate PP1 activity in the PSD.
In addition to PP1, the head-rod region of NF-L associates with the Rho-activated kinase, PKN (24) . Thus, NF-L may assemble a signaling complex where the close proximity of PKN and PP1 allows for cross-talk between the kinase and phosphatase to regulate the phosphorylation of NF-L and other neuronal substrates. In this regard, the M 110 subunit of PP1 binds the Rho-activated protein kinase, ROCK (66) . Following RhoA binding, ROCK phosphorylates both myosin and the M 110 subunit. Phosphorylation of the M 110 subunit inhibits PP1 activity and is essential for calcium-independent contraction of myosin in neurons (67) and in other cells (68 -69) . In contrast, RhoA binding to PKN (70 -71) promotes NF-L phosphorylation (24) . Whether NF-L phosphorylation also represents a mechanism for cross-talk between PKN and PP1 remains unknown, but the phosphorylation of the prototypic PP1-targeting subunit, G M , modulates both PP1 activity and its association with skeletal muscle glycogen (16) . Thus, PKN-mediated phosphorylation of NF-L could regulate PP1 association and/or activity against NF-L and other membrane and cytoskeletal phosphoproteins. Future studies directed at modifying the PP1/NF-L interaction, as well as the analysis of mice lacking a functional NF-L gene (72) , should define the importance of PP1 targeting to neurofilaments for neuronal morphology and plasticity.
